MARLBOROUGH, Mass.– ECI (Enhanced Compliance Inc.), a leading provider of regulatory, quality and engineering services and solutions for the life sciences industries, today announced the appointment of Brijesh Patel as the company’s new Chief Executive Officer (CEO), replacing Hoyt Randall Smith, who has announced his retirement. Mr. Patel, a co-founder of ECI and the company’s former Chief Compliance Officer (CCO), brings over 25 years of experience in life science industries to his new role.
Throughout his career, Brijesh Patel has been recognized for his deep expertise and impactful contributions to the medical device, pharmaceutical, and biotech industries. His professional journey includes consulting roles where he provided expert guidance to a diverse range of clients, addressing challenging regulatory compliance concerns.
Before transitioning into consulting, Mr. Patel held leadership positions at renowned organizations such as Teva Pharmaceuticals and Abbott Laboratories. His extensive experience and strategic vision enable him to deliver exceptional service across various verticals within the life sciences sector. Patel consistently drives organizational growth and continuous improvement through his strong technical acumen, collaborative leadership style, meticulous attention to detail, and unshakable work ethic.
“Brijesh Patel’s appointment as CEO marks an exciting new chapter for ECI,” said Hoyt Randall ‘Randy’ Smith, co-founder and former CEO of ECI. “His profound understanding of regulatory compliance and ability to provide strategic leadership will be invaluable as we expand our services and reach new heights in the industry.”
As a big-picture thinker and a structured problem-solver, Brijesh Patel boasts a proven track record of facilitating continuous improvement systems and processes. He is driven by the potential to make a lasting positive impact on businesses and lives across global borders. In an industry where quality improvement is an ongoing challenge, Brijesh is committed to supporting clients in managing regulatory complexities and ensuring compliance excellence.
“I am honored to serve as CEO for the company’s next chapter,” said Patel. “I look forward to leading our talented team as we continue to provide unparalleled full-product life cycle consulting services to our clients in the life science industry. Together, we will build on our strong foundation to drive sustained growth, enhanced capabilities, and innovative solutions that benefit our clients and the broader life sciences community. I, along with our entire organization, wish Randy a much-deserved retirement and we are blessed to have had his leadership over the last 12 years.”
ECI is dedicated to help life sciences organizations navigate the complex and dynamic regulatory landscape, As such, ECI recently announced the construction of a state-of-the-art, ISO 17025-certified packaging testing laboratory in Costa Rica’s Coyol Free Zone, representing a multi-million-dollar investment. This facility aims to fill a critical gap in technical research and development services, reducing time and costs for local companies that previously relied on U.S.-based suppliers. Benefiting sectors include medical devices, pharmaceuticals, biotechnology, and cosmetics. This lab demonstrates ECI’s impressive expansion and its strategic vision for the future.
The establishment of the new laboratory, overseen by new CEO Brijesh Patel, demonstrates ECI’s commitment to Costa Rica and its clients in LATAM. The company serves as a trusted advisor, offering transformative and sustainable solutions. The laboratory is set to begin operations in January 2025, creating 15 new jobs. Under Brijesh Patel’s leadership, the ECI is poised for continued, sustained growth and success, delivering exceptional value to its clients and making a meaningful difference in the industry.
